title: Acromegaly as an endocrine form of myopathy: case report and review of literature.
abstract: OBJECTIVE
  To describe a case of muscle weakness in a patient with acromegaly and to review the pathophysiologic features of this disorder.
  
  
  METHODS
  We present the clinical, laboratory, electromyographic, and muscle biopsy findings in our patient and review related reports in the literature.
  
  
  RESULTS
  A 58-year-old woman with acromegaly presented with complaints of bilateral hip pain, weakness, and instability 8 months after transsphenoidal resection of a growth hormone (GH)-secreting pituitary macroadenoma. She had biochemically normal thyroid and adrenal function and no evidence of any neuropathy, inflammatory myopathy, or rheumatologic disorder to explain her symptoms. Investigations revealed increased levels of GH, insulin-like growth factor-I, serum creatine kinase (CK), and the MB fraction of CK, normal results of nerve conduction studies, and nonspecific findings on electromyography and muscle biopsy. A review of the literature revealed that although muscle weakness is a well-recognized feature of acromegaly, only a few cases similar to ours have been reported since acromegaly was first described in the late 1800s. Little is known about the natural history, best diagnostic approach, and optimal therapy for this debilitating complication.
  
  
  CONCLUSIONS
  Muscle weakness in acromegaly is common and may result from a combination of the direct effect of GH excess on muscle and other metabolic derangements (hypothyroidism, hypoadrenalism, or diabetes). Mechanical factors may also contribute, such as joint laxity in conjunction with hypermobility. Affected patients may benefit from a reduction in GH levels and physiotherapy for adaptive training. Persistently increased serum CK levels in a patient with diabetes, for whom no other cause is found, should prompt an investigation for acromegaly. More research into this aspect of acromegaly is needed for enhancement of our understanding of, and therapy for, this debilitating condition.
authors: Department of Medicine, Division of Endocrinology, University of Saskatchewan, Canada S7N 0W8.
authors: Tammy L
authors: TL
authors: McNab
authors: Hasnain M
authors: HM
authors: Khandwala
mesh_terms: D000172:Acromegaly / Q000150:complications* / Q000503:physiopathology*; D005260:Female; D019382:Human Growth Hormone / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D018908:Muscle Weakness / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000473:pathology / Q000503:physiopathology
chemical_list: D019382:Human Growth Hormone